The dividend distribution will be payable on October 25, 2008 to stockholders of record as of the close of business on October 6, 2008. The Rights will expire in ten years. The Rights distribution is not taxable to stockholders.
ABOUT VANDA PHARMACEUTICALS INC.:
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders. For more on Vanda Pharmaceuticals Inc., please visit http://www.vandapharma.com.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
Various statements in this release are "forward-looking statements"
under the securities laws. Words such as, but not limited to, "believe,"
"expect," "anticipate," "estimate," "intend," "plan," "targets," "likely,"
"will," "would," and "could," and similar expressions or words, identify
forward- looking statements. Forward-looking statements are based upon
current expectations that involve risks, changes in circumstances,
assumptions and uncertainties. Vanda is at an early stage of development
and may not ever have any products that generate significant revenue.
Important factors that could cause actual results to differ materially from
those reflected in the company's forward-looking statements include, among
others: delays in the completion of Vanda's clinical trials; a failure of
Vanda's product candidates to be demonstrably safe and effective; Vanda's
failure to obtain regulatory approval for its products or to comply with
ongoing regulatory requirements; a lack of acceptance of Vanda's product
candidates in the
|SOURCE Vanda Pharmaceuticals Inc.|
Copyright©2008 PR Newswire.
All rights reserved